Zoran Zdraveski - Net Worth and Insider Trading
Zoran Zdraveski Net Worth
The estimated net worth of Zoran Zdraveski is at least $112,050 dollars as of 2024-11-29. Zoran Zdraveski is the See Remarks of Magenta Therapeutics Inc and owns about 128,009 shares of Magenta Therapeutics Inc (MGTA) stock worth over $89,555. Zoran Zdraveski is also the See Remarks of TScan Therapeutics Inc and owns about 4,716 shares of TScan Therapeutics Inc (TCRX) stock worth over $22,495. Details can be seen in Zoran Zdraveski's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Zoran Zdraveski has not made any transactions after 2024-08-23 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Zoran Zdraveski
Zoran Zdraveski Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Zoran Zdraveski owns 2 companies in total, including Magenta Therapeutics Inc (MGTA) , and TScan Therapeutics Inc (TCRX) .
Click here to see the complete history of Zoran Zdraveski’s form 4 insider trades.
Insider Ownership Summary of Zoran Zdraveski
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| MGTA | Magenta Therapeutics Inc | 2019-12-24 | See Remarks |
| TCRX | TScan Therapeutics Inc | 2024-08-23 | Chief Legal Officer |
Zoran Zdraveski Latest Holdings Summary
Zoran Zdraveski currently owns a total of 2 stocks. Among these stocks, Zoran Zdraveski owns 128,009 shares of Magenta Therapeutics Inc (MGTA) as of December 24, 2019, with a value of $89,555 and a weighting of 79.92%. Zoran Zdraveski also owns 4,716 shares of TScan Therapeutics Inc (TCRX) as of August 23, 2024, with a value of $22,495 and a weighting of 20.08%.
Latest Holdings of Zoran Zdraveski
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| MGTA | Magenta Therapeutics Inc | 2019-12-24 | 128,009 | 0.70 | 89,555 |
| TCRX | TScan Therapeutics Inc | 2024-08-23 | 4,716 | 4.77 | 22,495 |
Holding Weightings of Zoran Zdraveski
Zoran Zdraveski Form 4 Trading Tracker
According to the SEC Form 4 filings, Zoran Zdraveski has made a total of 3 transactions in Magenta Therapeutics Inc (MGTA) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Magenta Therapeutics Inc is the sale of 7,902 shares on December 24, 2019, which brought Zoran Zdraveski around $126,432.
According to the SEC Form 4 filings, Zoran Zdraveski has made a total of 2 transactions in TScan Therapeutics Inc (TCRX) over the past 5 years, including 1 buys and 1 sells. The most-recent trade in TScan Therapeutics Inc is the sale of 164,686 shares on August 23, 2024, which brought Zoran Zdraveski around $951,885.
Insider Trading History of Zoran Zdraveski
- 1
Zoran Zdraveski Trading Performance
GuruFocus tracks the stock performance after each of Zoran Zdraveski's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Zoran Zdraveski is -36.8%. GuruFocus also compares Zoran Zdraveski's trading performance to market benchmark return within the same time period. The performance of stocks bought by Zoran Zdraveski within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Zoran Zdraveski's insider trading performs compared to the benchmark.
Performance of Zoran Zdraveski
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 1.3 | | | | | |
| Relative Return to S&P 500(%) | -0.86 | | | | | |
Zoran Zdraveski Ownership Network
Zoran Zdraveski Owned Company Details
What does Magenta Therapeutics Inc do?
Who are the key executives at Magenta Therapeutics Inc?
Zoran Zdraveski is the See Remarks of Magenta Therapeutics Inc. Other key executives at Magenta Therapeutics Inc include director & 10 percent owner Peter Evan Harwin , director & 10 percent owner Tomas Kiselak , and director & 10 percent owner Fairmount Funds Management Llc .
Magenta Therapeutics Inc (MGTA) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Magenta Therapeutics Inc (MGTA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Magenta Therapeutics Inc (MGTA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Magenta Therapeutics Inc (MGTA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Magenta Therapeutics Inc Insider Transactions
Zoran Zdraveski Mailing Address
Above is the net worth, insider trading, and ownership report for Zoran Zdraveski. You might contact Zoran Zdraveski via mailing address: C/o Magenta Therapeutics, 50 Hampshire Street, Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
